Omzo vs Gala: Compare Compounded GLP-1 Care and Pricing

Omzo vs Gala: both offer compounded semaglutide and tirzepatide through telehealth, but they differ in pricing structure, clinician model, medication sourcing, shipping, and how costs are presented. Early verdict: choose Omzo if you want clinician-guided plans with published starting prices; choose Gala if you prefer a flat bundled price with included provider visit and fast shipping.

See Omzo clinician-guided pricing and options

Head-to-head overview of Omzo vs Gala

This comparison focuses on five clear differences surfaced in the sources: pricing and price transparency, clinical model and provider role, medication type and dispensing, shipping and delivery, and regulatory notes about compounded drugs.

1. Pricing structure and transparency

Omzo lists specific starting prices: semaglutide starting at $179 and tirzepatide starting at $279. Gala promotes a flat all-inclusive price model with a $220 promotion visible on the landing page, but the base dollar price was not exposed in readable page text. That means Omzo provides clear published starting prices while Gala presents a bundled, promotional offer with some base pricing details not directly visible.

Check Gala flat-price plans and promotion

2. Clinical model and what the provider does

Omzo describes clinician-guided plans reviewed by licensed U.S. providers and emphasizes that clinical services are provided by third party networks of U.S.-licensed clinicians who determine eligibility and make the final prescription decision. Gala advertises that a provider visit and prescription are included as part of its direct-pay telehealth platform with provider check-ins and dose monitoring included. Both require a clinician to determine medical appropriateness, but Omzo highlights provider review of plans while Gala highlights included visit and ongoing check-ins.

3. Medication sourcing and prescription handling

Omzo connects users to licensed medical providers who may prescribe either compounded medications via a state-licensed sterile compounding pharmacy or prescriptions for branded medications, noting that Omzo does not sell, dispense, or ship branded medications and that if prescribed a branded medication the patient is responsible for filling it at their chosen pharmacy. Gala offers compounded semaglutide and tirzepatide as direct-pay options with prescription and provider visit included. Both sources explicitly state that compounded medications, when offered, are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.

4. Shipping, delivery, and membership terms

Omzo mentions fast, discreet delivery and that medication costs are included in fees collected by Omzo with pharmacies paid by Omzo. Gala advertises free two-day shipping, no monthly membership, and a cancel anytime policy. Gala emphasizes a same price at every dose claim and no hidden fees as part of a bundled offering. Omzo notes that rates and availability may vary by state and other factors and that eligibility and renewal terms should be confirmed before enrollment.

Concise comparison table

What the sources say about outcomes and claims

Both pages include user testimonials or examples. Omzo shares an example quote about three months of personalized GLP-1 care and steady weekly progress, while Gala highlights customer weight-change examples and a promotional claim such as 28 pounds in three months. Both sources state that individual results may vary and that treatment is available only when a licensed clinician determines it is medically appropriate. Gala notes marketing claims and testimonials; Omzo states that figures do not represent clinical outcomes and that eligibility and results are not guaranteed.

View Omzo plans and clinician details

How to decide between Omzo vs Gala

If you prioritize transparent, published starting prices and a clinician-reviewed plan model, Omzo may be a better fit since it lists semaglutide starting at $179 and tirzepatide at $279 and emphasizes clinician-guided plans reviewed by licensed U.S. providers. If you prefer a bundled flat price that includes the provider visit, prescription, ongoing check-ins, and free two-day shipping, Gala may match your needs, though the base dollar price was not visible in readable page text and a $220 promotion is featured on the landing page.

Explore Gala flat-price plan and shipping

Choose Provider guidance

Choose Omzo if you want clinician-guided plans reviewed by licensed U.S. providers and published starting prices for compounded semaglutide starting at $179 and tirzepatide starting at $279. Confirm eligibility, medication options, total cost, renewal terms, and state availability before enrolling. Choose Gala if you want a single flat all-inclusive price that covers the provider visit, prescription, ongoing check-ins, and free two-day shipping and you are comfortable that the landing page shows a $220 promotion while the base price was not exposed in readable text.